MCD•October 21, 2026 at 2:31 PM UTCConsumer Services

McDonald's Menu Innovation Not Yet a Proven Fix for Weak U.S. Traffic

Read source article

What happened

McDonald's faces continued pressure to lift U.S. comparable sales as customer traffic remains weak, and menu innovation is being pitched as a potential offset. The latest article highlights that new products could attract customers and expand categories, but the recent Q2 2026 data show U.S. comps rose only 0.8% with guest counts still negative. The company's beverage platform, including Refreshers and Crafted Sodas, shows early promise, but it has not yet translated into measurable traffic growth. At $244, the stock trades below the base-case implied value of $248 and reflects a wait-and-see stance from investors. The next two reported quarters will be critical in determining whether menu news can restore transaction growth without requiring heavier franchisee support.

Implication

Investors should maintain a wait-and-see approach with MCD at current levels. The stock's attractive entry point is near $228, while a trim above $272 would imply the traffic recovery is being fully priced in. Until U.S. comparable guest counts turn positive, the fundamental case for a re-rating remains unproven. Menu innovation, particularly in beverages, offers a credible path to incremental visits, but execution and franchisee adoption risk are high. A disciplined stance is warranted until the company demonstrates that capex remains within guided levels and that new products are driving actual transactions rather than just check growth.

Thesis delta

The thesis remains unchanged: MCD is a high-quality franchise model but is in a show-me phase on U.S. traffic recovery. The recent article reinforces existing concerns about weak guest counts but does not introduce new data that would alter the WAIT rating or valuation ranges. The key monitor remains whether next-quarter results show transaction growth and whether franchisee support stays within guided capex.

Confidence

Medium